ImmusanT

Immusan T

Other, One Kendall Square, Cambridge, , 2139, Massachusetts, United States, 1-10 Employees

immusant.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +16*********

Who is IMMUSANT

ImmusanT, Inc. | 760 followers on LinkedIn. ImmusanT is a privately held biotechnology company focused on protecting patients with celiac disease against the effects of gluten. By harness...

Read More

map
  • One Kendall Square, Cambridge, Massachusetts, 2139, United States Headquarters: One Kendall Square, Cambridge, Massachusetts, 2139, United States
  • 2010 Date Founded: 2010
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Other

SIC SIC Code: 2835 | NAICS Code: 325413 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from IMMUSANT

ImmusanT Org Chart and Mapping

Employees

Suyue Wang

Director of Assay Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ImmusanT

Answer: ImmusanT's headquarters are located at One Kendall Square, Cambridge, , 2139, Massachusetts, United States

Answer: ImmusanT's phone number is +16*********

Answer: ImmusanT's official website is https://immusant.com

Answer: ImmusanT's revenue is Under $1 Million

Answer: ImmusanT's SIC: 2835

Answer: ImmusanT's NAICS: 325413

Answer: ImmusanT has 1-10 employees

Answer: ImmusanT is in Other

Answer: ImmusanT contact info: Phone number: +16********* Website: https://immusant.com

Answer: ImmusanT, Inc. | 760 followers on LinkedIn. ImmusanT is a privately held biotechnology company focused on protecting patients with celiac disease against the effects of gluten. By harnessing new discoveries in immunology ImmusanT aims to improve diagnosis and medical management of celiac disease byprotecting against the effects of gluten exposure while patients maintain a gluten free diet. The company is developing Nexvax2®, a therapeutic vaccine for celiac disease, and diagnostic and monitoring tools to improve celiac disease management.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access